News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
47,817 Results
Type
Article (2793)
Company Profile (6)
Press Release (45018)
Section
Business (12643)
Career Advice (29)
Deals (2193)
Drug Delivery (6)
Drug Development (6668)
Employer Resources (2)
FDA (1858)
Job Trends (1315)
News (23884)
Policy (2604)
Tag
2024 Biotech Bay Standard (1)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (1)
2024 Pharm Country Digital (1)
2026 Genetown Elite (1)
Academia (155)
Accelerated approval (1)
Allergies (8)
Alliances (4473)
ALS (14)
Alzheimer's disease (134)
Antibody-drug conjugate (ADC) (14)
Approvals (1912)
Artificial intelligence (12)
Autoimmune disease (1)
Automation (1)
Bankruptcy (7)
Best Places to Work (1212)
BIOSECURE Act (3)
Biosimilars (12)
Biotechnology (2)
Bladder cancer (8)
Brain cancer (5)
Breast cancer (23)
Cancer (247)
Cardiovascular disease (18)
Career advice (29)
CAR-T (12)
Cell therapy (36)
Cervical cancer (4)
Clinical research (5982)
Collaboration (94)
Compensation (1)
Complete response letters (3)
COVID-19 (195)
CRISPR (1)
C-suite (13)
Cystic fibrosis (5)
Data (231)
Depression (1)
Diabetes (7)
Diagnostics (406)
Drug discovery (16)
Drug pricing (4)
Drug shortages (2)
Duchenne muscular dystrophy (10)
Earnings (5168)
Editorial (3)
Employer resources (2)
Events (4785)
Executive appointments (42)
FDA (2008)
Featured Employer (2)
Funding (31)
Gene editing (3)
Generative AI (2)
Gene therapy (18)
GLP-1 (38)
Government (236)
Grass and pollen (2)
Guidances (3)
Healthcare (932)
Huntington's disease (1)
IgA nephropathy (6)
Immunology and inflammation (16)
Indications (2)
Infectious disease (217)
Inflammatory bowel disease (23)
Influenza (9)
Intellectual property (15)
Interviews (2)
IPO (859)
IRA (2)
Job creations (184)
Job search strategy (27)
Kidney cancer (5)
Layoffs (30)
Legal (313)
Liver cancer (4)
Lung cancer (39)
Lymphoma (34)
Management (1)
Manufacturing (31)
MASH (8)
Medical device (873)
Medtech (873)
Mergers & acquisitions (1372)
Metabolic disorders (32)
Multiple sclerosis (5)
NASH (1)
Neurodegenerative disease (10)
Neuropsychiatric disorders (1)
Neuroscience (187)
NextGen: Class of 2025 (254)
Non-profit (169)
Northern California (130)
Now hiring (1)
Obesity (14)
Opinion (12)
Ovarian cancer (2)
Pain (4)
Pancreatic cancer (5)
Parkinson's disease (16)
Partnered (2)
Patents (35)
Patient recruitment (9)
People (2537)
Pharmaceutical (4)
Phase I (1058)
Phase II (1965)
Phase III (3284)
Pipeline (130)
Policy (8)
Postmarket research (259)
Preclinical (290)
Press Release (43)
Prostate cancer (16)
Radiopharmaceuticals (45)
Rare diseases (28)
Real estate (382)
Recruiting (1)
Regulatory (2315)
Reports (12)
Research institute (107)
RSV (6)
Schizophrenia (11)
Series A (8)
Series B (5)
Service/supplier (1)
Sickle cell disease (1)
Southern California (180)
Spinal muscular atrophy (41)
Sponsored (5)
Startups (184)
Stomach cancer (2)
Supply chain (4)
Tariffs (1)
United States (1349)
Vaccines (46)
Venture capitalists (2)
Weight loss (7)
Women's health (5)
Date
Today (17)
Last 7 days (52)
Last 30 days (206)
Last 365 days (2834)
2025 (926)
2024 (2756)
2023 (2788)
2022 (6049)
2021 (4538)
2020 (3888)
2019 (2982)
2018 (2373)
2017 (2546)
2016 (2292)
2015 (2563)
2014 (1774)
2013 (1463)
2012 (1607)
2011 (1856)
2010 (1509)
Location
Africa (52)
Alabama (1)
Alaska (1)
Arizona (9)
Asia (8043)
Australia (684)
California (353)
Canada (93)
China (70)
Colorado (2)
Connecticut (26)
Delaware (29)
Europe (8607)
Florida (37)
Georgia (20)
Illinois (19)
India (6)
Indiana (47)
Japan (143)
Kansas (1)
Maine (4)
Maryland (19)
Massachusetts (247)
Michigan (9)
Minnesota (3)
Missouri (4)
Nebraska (1)
Nevada (3)
New Hampshire (1)
New Jersey (254)
New York (123)
North Carolina (23)
Northern California (130)
Ohio (4)
Oklahoma (1)
Oregon (1)
Pennsylvania (58)
Rhode Island (1)
South America (85)
South Carolina (1)
Southern California (180)
Tennessee (1)
Texas (44)
Utah (7)
Virginia (4)
Washington D.C. (2)
Washington State (24)
Wisconsin (5)
47,817 Results for "japan lifeline".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Gene therapy
Lilly Throws Sangamo a Lifeline With Pact Worth Potential $1.4B+
Sangamo, which has been having cash problems, will receive $18 million upfront in licensing fees for its AAV capsid that in preclinical studies has shown the ability to cross the blood-brain barrier.
April 4, 2025
·
2 min read
·
Tristan Manalac
Drug Development
Site Survival: Why Clinical Research Sites Need a Lifeline
Elisa Cascade, CPO at Advarra explains why addressing the challenges faced by clinical research sites is vital for improving patient trust and the overall viability of clinical trials.
February 19, 2025
·
1 min read
·
Lori Ellis
Press Releases
LIVMARLI Now Approved in Japan for ALGS and PFIC
March 28, 2025
·
7 min read
Press Releases
Adragos Pharma Expands in Japan: Strengthening Production, Quality, and Trust
April 8, 2025
·
1 min read
Press Releases
SNBL and Tasso, Inc. to Establish Joint Venture in Japan
March 28, 2025
·
2 min read
Press Releases
KalVista Pharmaceuticals Enters Into Licensing Agreement With Kaken Pharmaceutical to Commercialize Sebetralstat for HAE in Japan
April 8, 2025
·
4 min read
Layoffs
Astellas Cuts 24 Universal Cells Roles in Seattle, Transfers 12 to Japan
Astellas is opening a second location of Universal Cells, its wholly owned subsidiary, at a research campus in Japan and transferring 12 roles from Universal’s Seattle location.
October 10, 2024
·
1 min read
·
Angela Gabriel
Press Releases
Strong sales for Cresemba® (isavuconazole) in Japan trigger second milestone payment from Asahi Kasei Pharma to Basilea
April 24, 2025
·
3 min read
Press Releases
National Cancer Center Japan and PeptiDream: New Radiopharmaceuticals for Renal Cell Carcinoma
March 31, 2025
·
10 min read
Press Releases
GE HealthCare Completes Acquisition of Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan
March 31, 2025
·
4 min read
1 of 4,782
Next
